Mark For: RLF-100™ trademark registration is intended to cover the categories of
Website | www.neurorxpharma.com |
Research | OneLook Acronym Finder |
Serial Number | 90110838 |
Mark Literal Elements | RLF-100 |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 130 - EXAMINING ATTORNEY ASSIGNED 2021-02-04 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Brian Del Buono |
2020-03-01 | Date of First Use |
2020-05-01 | Date of Use In Commerce |
2020-08-13 | Application Filed |
2020-08-17 | Location: NEW APPLICATION PROCESSING |
2020-08-17 | Status: Live/Pending |
2020-08-17 | Transaction Date |
2021-02-04 | Location: TMO LAW OFFICE 130 - EXAMINING ATTORNEY ASSIGNED |
2021-02-11 | Status: Abandoned because the applicant filed an express abandonment. To view all documents in this file, click on the Trademark Documen |
Party: | NeuroRx, Inc. |
Address | Suite 200 913 North Market Street, Suite 200 Wilmington, DELAWARE UNITED STATES 19801 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | 2020-08-13 | |
Specimen | 2020-08-13 | |
TEAS Plus New Application | 2020-08-13 | |
XSearch Search Summary | 2021-02-03 | |
Notation to File | 2021-02-04 | |
Suspension Letter | 2021-02-04 | |
Express Abandonment | 2021-02-10 | |
Notice of Abandonment | 2021-02-11 |
(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections. FIRST USE: 20200301. FIRST USE IN COMMERCE: 20200501
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections |
Description | Date | Proceeding Number |
---|---|---|
ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | 2021-02-11 | |
ABANDONMENT - EXPRESS MAILED | 2021-02-11 | |
TEAS EXPRESS ABANDONMENT RECEIVED | 2021-02-10 | |
SUSPENSION LETTER WRITTEN | 2021-02-04 | 76419 |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2021-02-04 | 6332 |
LETTER OF SUSPENSION E-MAILED | 2021-02-04 | 6332 |
ASSIGNED TO EXAMINER | 2021-01-28 | 76419 |
ASSIGNED TO EXAMINER | 2020-11-23 | 77656 |
ASSIGNED TO EXAMINER | 2020-11-21 | 88570 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-09-15 | |
NEW APPLICATION ENTERED IN TRAM | 2020-08-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.